Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells

Journal of Virology

Volumn 74, Issue 20, 2000, Pages 9637-9645

  Krithivas, A ^a   Young, D B ^a   Liao, G ^a   Greene, D ^a   Hayward, S D ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; VIRUS CARCINOGENESIS; VIRUS EXPRESSION; VIRUS LATENCY; VIRUS TRANSCRIPTION;

ANTIGENS, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HERPESVIRUS 8, HUMAN; HISTONE DEACETYLASES; HUMAN; NUCLEAR PROTEINS; REPRESSOR PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0033809462     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.20.9637-9645.2000     Document Type: Article

References (73)

1. Characterization of intertypic recombinants of the Epstein-Barr virus from the body-cavity-based lymphoma cell lines BC-1 and BC-2
2. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein
3. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen
4. Cooperation of Stat2 and p300/CBP in signalling induced by interferon-α
5. Methylation-induced repression-belts, braces, and chromatin
6. Establishing a KSHV negative cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice
7. Kaposi's sarcoma-associated herpesvirus infected endothelial and spindle cells
8. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: Potential switches in latent gene expression due to coinfection
9. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
10. In vitro establishment and characterization of two AIDS-related lymphoma cell lines containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences
11. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma
12. The Epstein-Barr virus Zta transactivator: A member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif
13. The Epstein-Barr virus latency Qp promoter is positively regulated by STATs and Zta interference with JAK-STAT activation leads to loss of Qp activity
14. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells
15. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus
16. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma
17. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
18. p53 inhibition by the LANA protein of KSHV protects against cell death
19. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
20. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
21. Human herpesvirus 8 (Kaposi's sarcoma herpesvirus) and malignant lymphoproliferations in France: A molecular study of 250 cases including two AIDS-associated body cavity based lymphomas
22. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8
23. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2
24. CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex
25. Primary body cavity-based AIDS-related lymphomas. Evolution of a new disease entity
26. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
27. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway
28. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma
29. Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus
30. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
31. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome
32. Characterization of monoclonal antibodies raised against the latent nuclear antigen of human herpesvirus 8
33. Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8
34. Sin meets NuRD and other tails of repression
35. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
36. Histone deacetylases associated with the mSin3 corepressor mediate Mad transcriptional repression
37. Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus
38. p300 stimulates transcription instigated by ligand-bound thyroid hormone receptor at a step subsequent to chromatin disruption
39. Contribution of conserved amino acids in mediating interaction between EBNA2 and CBF1/RBPJk
40. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif
41. Epstein-Barr virus shuttle vector for stable episomal replication of cDNA expression libraries in human cells
42. Immunoglobulin VH gene mutational analysis suggests that primary effusion lymphomas derive from different stages of B cell maturation
43. Posttransplantation plasmacytic proliferations related to Kaposi's sarcoma-associated herpesvirus
44. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells
45. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection
46. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas
47. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
48. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
49. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma
50. Primary effusion lymphoma: A distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpesvirus
51. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase
52. Novel organization features, captured cellular genes and strain variability within the genome of KSHV/HHV8
53. Detection of heterogenous Epstein-Barr virus gene expression patterns with individual post-transplantation lymphoproliferative disorders
54. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
55. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals
56. Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene
57. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen
58. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions
59. Methylation of the Epstein-Barr virus genome in normal lymphocytes
60. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV8)
61. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)
62. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter
63. Host cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs
64. Kaposi's sarcoma-associated herpesvirus-like DNA sequenses in multicentric Castleman's disease
65. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line
66. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies
67. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line
68. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue
69. Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease
70. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter
71. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain
72. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease
73. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex